|
FDA Approves New Indication for J&J’s Nucynta for Diabetic Neuropathy Pain
The FDA has approved an sNDA for Janssen Pharmaceuticals’ Nucynta ER to manage severe pain in diabetic peripheral neuropathy (DPN).
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives